The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Abstract
To date, data on pituitary adenomas in MEN type 1 (MEN1) still have to be evaluated. We analyzed the data of a large series of 324 MEN1 patients from a French and Belgian multicenter study. Data on pituitary disease were compared with those from 110 non-MEN1 patients with pituitary adenomas, matched for age, year of diagnosis, and follow-up period. Genetic analysis of the MEN1 gene was performed in 197 of the MEN1 patients. In our MEN1 series, pituitary disease occurred in 136 of 324 (42%), less frequently than hyperparathyroidism (95%, P < 0.001) and endocrine enteropancreatic tumors (54%, P < 0.01). Mean age of onset of pituitary tumors was 38.0+/-15.3 yr (range, 12-83 yr). Pituitary disease was associated with hyperparathyroidism in 90% of cases, with enteropancreatic tumors in 47%, with adrenal tumors in 16%, and with thoracic neuroendocrine tumors in 4%. Pituitary disease was the initial lesion of MEN1 in 17% of all MEN1 patients. MEN1 pituitary adenomas were significantly more frequent in women than in men (50% vs. 31%, P < 0.001). Among the 136 pituitary adenomas, there were 85 prolactinomas and 12 GH-secreting, 6 ACTH-secreting, 13 cosecreting, and 20 nonsecreting tumors. Eighty-five percent of MEN1-related pituitary lesions were macroadenomas (vs. 42% in non-MEN1 patients, P < 0.001), including 32% of invasive cases. Among secreting adenomas, hormonal hypersecretion was normalized, after treatment, in only 42% (vs. 90% in non-MEN1 patients, P < 0.001), with a median follow-up of 11.4 yr. No correlation was found between the type of MEN1 germ-line mutation and the presence or absence of pituitary adenoma. Our study, based on a large group of MEN1 patients, shows that pituitary adenomas occur in 42% of the cases and are characterized by a larger size and a more aggressive presentation than without MEN1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Lemmens, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1177 · Cited by 611
Agarwal, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1169 · Cited by 477
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Trump, D., Farren, B., Wooding, C., Pang, J. T., Besser, G. M., Buchanan, K. D., Edwards, C. R., Heath, D. A., Jackson, C. E., Jansen, S., et al. (1996) · QJM · doi:10.1093/qjmed/89.9.653 · Cited by 471
Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1
Bassett, J. H. D., Forbes, S. A., Pannett, A. A. J., Lloyd, S. E., Christie, P. T., Wooding, C., Harding, B., Besser, G. M., Edwards, C. R., Monson, J. P., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301729 · Cited by 444
FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX
BALLARD, H. S., FRAME, B., & HARTSOCK, R. J. (1964) · Medicine · doi:10.1097/00005792-196407000-00003 · Cited by 439
Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics
Marx, S., Spiegel, A. M., Skarulis, M. C., Doppman, J. L., Collins, F. S., & Liotta, L. A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00011 · Cited by 368
Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang, Z., Ezzat, S., Vortmeyer, A. O., Weil, R. J., Oldfield, E. H., Park, W. S., Pack, S., Huang, S. C., Agarwal, S. K., Guru, S. C., et al. (1997) · PubMed · Cited by 246
Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*
SKOGSEID, B., ERIKSSON, B., LUNDQVIST, G., LÖRELIUS, L.-E., RASTAD, J., WIDE, L., ÅKERSTRÖM, G., & ÖBERG, K. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-281 · Cited by 232
UMD (Universal Mutation Database): A generic software to build and analyze locus-specific databases
Béroud, C., Collod‐Béroud, G., Boileau, C., Soussi, T., & Junien, C. (2000) · Human Mutation · Cited by 228
Giraud, S., Zhang, C. X., Serova-Sinilnikova, O., Wautot, V., Salandre, J., Buisson, N., Waterlot, C., Bauters, C., Porchet, N., Aubert, J.-P., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301953 · Cited by 211
Self-citationEndocrine adenomatosis and peptic ulcer in a large kindred
Wermer, P. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90212-2 · Cited by 201
Familial Multiple Endocrine Neoplasia Type I: A New Look at Pathophysiology
BRANDI, M. L., MARX, S. J., AURBACH, G. D., & FITZPATRICK, L. A. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-4-391 · Cited by 185
The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1
Carty, S. E., Helm, A. K., Amico, J. A., Clarke, M. R., Foley, T. P., Watson, C. G., & Mulvihill, J. J. (1998) · Surgery · doi:10.1067/msy.1998.93107 · Cited by 182
The Natural History of Multiple Endocrine Neoplasia Type 1: Highly Uncommon or Highly Unrecognized?
Shepherd, J. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410320017001 · Cited by 163
Primary Medical Therapy of Micro- and Macroprolactinomas in Men
Pinzone, J. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3053 · Cited by 161
Diagnosis and Treatment of Pituitary Tumors
Freda, P. U. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.3859 · Cited by 158
Pituitary adenomas of the multiple endocrine neoplasia type I syndrome.
Scheithauer, B. W., Laws, E. R., Kovács, K., Horváth, É., Randall, R. V., & Carney, J. A. (1987) · PubMed · Cited by 150
Molecular characterization of the
Kersten, M. A. S. H., Müller, Y. U. R., den Camp, H. J. M. O., Vogels, G. D., Griensven, L. J. L. D. V., Visser, J., & Schaap, P. J. (1997) · Molecular and General Genetics MGG · doi:10.1007/s004380050559 · Cited by 117
Burgess, J. R., Shepherd, J. J., Parameswaran, V., Hoffman, L., & Greenaway, T. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675591 · Cited by 116
Tanaka, C., Yoshimoto, K., Yamada, S., Nishioka, H., Ii, S., Moritani, M., Yamaoka, T., & Itakura, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4653 · Cited by 107
The MEA-I syndrome: an all or none phenomenon?
Majewski, J., & Wilson, S. D. (1979) · PubMed · Cited by 100
Hyperprolactinemia, Amenorrhea, and Galactorrhea: A Retrospective Assessment of Twenty-five Cases
KOPPELMAN, M. C. S., JAFFE, M. J., RIETH, K. G., CARUSO, R. C., & LORIAUX, D. L. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-1-115 · Cited by 92
Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types
Corbetta, S., Pizzocaro, A., PERACCHI, M., Beck‐Peccoz, P., Faglia, G., & Spada, A. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.3311122.x · Cited by 90
Colao, A. A. L., Annunziato, L., & Lombardi, G. (1998) · Annals of Medicine · doi:10.3109/07853899809002486 · Cited by 73
Burgess, J. R., Shepherd, J. J., Parameswaran, V., Hoffman, L., & Greenaway, T. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626844 · Cited by 73
Results of Treatment of Pituitary Disease in Multiple Endocrine Neoplasia, Type I
O’Brien, T., O'Riordan, D., Gharib, H., Scheithauer, B. W., Ebersold, M. J., & van Heerden, J. A. (1996) · Neurosurgery · doi:10.1097/00006123-199608000-00008 · Cited by 69
Clinical management of prolactinomas
Webster, J. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0030 · Cited by 62
Pituitary Disorders: Drug Treatment Options
Orrego, J. J., & Barkan, A. L. (2000) · Drugs · doi:10.2165/00003495-200059010-00006 · Cited by 55
Multiple Endocrine Neoplasia Type 1 (MEN-1) Clinical, biochemical and genetical investigations
Ouberg, K., Skogseid, B. M., & Eriksson, B. K. (1989) · Acta Oncologica · doi:10.3109/02841868909111211 · Cited by 53
Management of Patients and Subjects at Risk for Multiple Endocrine Neoplasia Type 1: MEN 1
Chanson, P., Cadiot, G., & Murat, A. (2008) · Hormone Research · doi:10.1159/000185466 · Cited by 40
Self-citationVenkatesh (1989) · doi:10.1002/1097-0142(19890801)64:3
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
The Human Obesity Gene Map: The 2005 Update
Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Pérusse, L., & Bouchard, C. (2006) · Obesity · doi:10.1038/oby.2006.71 · Cited by 1,119
High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium
Daly, A. F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M. A., & Beckers, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1668 · Cited by 1,025
Self-citationGuidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Casanueva, F. F., Molitch, M. E., Schlechte, J. A., Abs, R., Bonert, V., Bronstein, M. D., Brue, T., Cappabianca, P., Colao, A., Fahlbusch, R., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02562.x · Cited by 829
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Metadata
- Authors
- Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C., & Calender, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-02
- Volume
- 87
- Issue
- 2
- Pages
- 457-465
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2058174004
- Cited by
- 483
- References
- 33
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.